Eleanor Stuart

Eleanor Stuart has worked as a Life Science Researcher at Airfinity Ltd since August 2021. Prior to that, they conducted a fourth-year research project at the University of Cambridge from October 2020 to March 2021. In this role, they focused on researching the effect of the anti-viral drug vidarabine on DNA replication using budding yeast as a model organism. Eleanor gained experience in various techniques such as cloning, mutagenesis, PCR, flow cytometry, and western blotting. Eleanor also utilized Unix and R for data analysis of DNA sequencing data.

Before their fourth-year project, Eleanor was involved in a third-year research project at the University of Cambridge from January 2020 to March 2020. During this project, they investigated the impact of ApoE isoforms on microglial phagocytosis and TREM2 activation in the context of Alzheimer's Disease. Eleanor gained experience with techniques such as cell culture, flow cytometry, reporter cell lines, and immunofluorescence. Eleanor also had the opportunity to write up their research and discuss its implications within the field.

Additionally, Eleanor was a Summer Intern at the University of Oxford from July 2019 to September 2019. Their work focused on the effect of gestational diabetes on embryonic heart development. In this role, they utilized techniques like histology, immunohistochemistry, and 3D modeling of hearts using Amira.

Eleanor Stuart attended the University of Cambridge from 2017 to 2021, where they pursued a degree in Natural Sciences. Their field of study was specifically focused on Biochemistry.